Evidence check: AMH in the context of gut health

The question of AMH (anti-Müllerian hormone) in the context of gut health currently lacks robust scientific evidence. AMH is a well-established marker of ovarian reserve used in fertility medicine. There are no direct, reproducible studies showing that gut microbiota composition or gut health significantly alter AMH levels. Some speculative mechanisms—such as systemic inflammation or microbiome influence on hormone metabolism—have been proposed, but remain unproven. Existing data from nutrigenetics and microbiome research are too weak to support a clinical recommendation. An AMH test as part of a gut health assessment is therefore not indicated. If someone still takes such a test, the results should not be interpreted as a measure of gut health. Instead, established markers like calprotectin, zonulin, or stool microbiome diversity are more informative. Evidence: unclear – no direct human studies linking AMH to gut parameters. Sources: none from the provided context.